The Drugs for Neglected Diseases initiative (DNDi) is an independent, non-profit partnership working to research and develop new and improved treatments for neglected diseases such as visceral leishmaniasis also known as kala azar (cutaneous and muco-cutaneous forms), sleeping sickness (human African trypanosomiasis), Chagas disease and malaria.
The initiative was founded in 2003 by the Brazilian Oswaldo Cruz Foundation/Farmanguinhos, the Indian Council for Medical Research, the Kenya Medical Research Institute, the Ministry of Health of Malaysia, the Pasteur Institute in France, and MSF. The World Health Organization’s Special Programme for Research and Training in Tropical Diseases is a permanent observer.
MSF is part of the scientific advisory group and has seats on the board.
To learn more, please visit www.dndi.org
- Chagas diseaseApply Chagas disease filter (4)
- Dengue feverApply Dengue fever filter (1)
- HIV / AIDSApply HIV / AIDS filter (3)
- Infectious diseasesApply Infectious diseases filter (1)
- Kala azar (visceral leishmaniasis)Apply Kala azar (visceral leishmaniasis) filter (5)
- LeishmaniasisApply Leishmaniasis filter (5)
- MalariaApply Malaria filter (5)
- Multidrug-resistant tuberculosis (MDR-TB)Apply Multidrug-resistant tuberculosis (MDR-TB) filter (1)
- Parasitic diseasesApply Parasitic diseases filter (5)
- Sleeping sickness (human African trypanosomiasis)Apply Sleeping sickness (human African trypanosomiasis) filter (7)
- TuberculosisApply Tuberculosis filter (2)